Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes

Cancer Research

Volumn 57, Issue 4, 1997, Pages 659-671

  Duncan, James R ^a   Stephenson, Mary T ^a   Wu, Herman P ^a   Anderson, Carolyn J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDIUM 111; PENTETREOTIDE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; DRUG DISTRIBUTION; DRUG TARGETING; DRUG TRANSPORT; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LYSOSOME; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; ANIMALS; FEMALE; INDIUM RADIOISOTOPES; KIDNEY NEOPLASMS; LIVER; LYSOSOMES; OCTREOTIDE; PANCREAS; PANCREATIC NEOPLASMS; PENTETIC ACID; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0031050737     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Rauh, D. A. Progress and promise. J. Nucl. Med., 35: 1858-1860, 1994.
2. 123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. EUT. J. Nucl. Med., 20: 716-731, 1993.
3. Fischman, A. J., Babich, J. W., and Strauss, H. W. A ticket to ride: peptide radiopharmaceuticals. J. Nucl. Med., 34: 2253-2263, 1993.
4. Draznin, B., Sherman, N., Sussman, K., Dahl, R., and Vatter, A. Internalization and cellular processing of somatoslatin in primary culture of rat anterior pituitary cells. Endocrinology, 117: 960-966, 1985.
5. Morel, G., Leroux, P., and Pelletier, G. Ultrastructural autoradiographic localization of somatostatin-28 in the rat pituitary gland. Endocrinology, 116: 1615-1620, 1985.
6. Morel, G., Pelletier, G., and Heisler, S. Internalization and subcellular distribution of radiolabeled somatostatin-28 in the mouse anterior pituitary tumor cells. Endocrinology, 119: 1972-1979, 1986.
7. 3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Endocrinology, 136: 3698-3706, 1995.
8. Amherdt, M., Patel, Y., and Orci, L. Binding and internalization of somatostatin, insulin and glucagon by cultured rat islet cells. J. Clin. Invest., 84: 412-417, 1989.
9. 1 rat pituitary cells. J. Cell Biol., 102: 878-888, 1986.
10. 11]somatostatin by RINm5F insulinoma cells. J. Biol. Chem., 261: 3571-3577, 1986.
11. Krenning, E. P., Bakker, W. H., Kooij, P. P., Breeman, W. A., Oei, H. Y., de Jong, M., Reubi, J. C., Visser, T. J., Bruns, C., Kwekkeboom, D. J., Reijs, A. E. M., van Hagen, P. M., Koper, J. W., and Lamberts, S. W. J. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-l-octreotide in man: metabolism, dosimetry and comparison with iodine- 123-Tyr-3-octreotide. J. Nucl. Med., 33: 652-658, 1992.
12. Duncan, J. R., and Welch, M. J. Intracellular metabolism of indium-111-DTPA labeled receptor targeted proteins. J. Nucl. Med., 34: 1728-1738, 1993.
13. Arano, Y., Mukai, T., Uezono, T., Wakisaka, K., Motonari, H., Akizawa, H., Taoka, Y., and Yokoyoma, A. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides. J. Nucl. Med., 35: 890-898, 1994.
14. 111In-DTPA-e-lysine as the primary metabolic and excretory product. Nucl. Med. Biol., 27: 1023-1034, 1994.
15. Wattiaux, R., Wattiaux-De Coninck, S., Rutgeerts, M-J., and Tulkens, P. Influence of the injection of a sucrose solution on the properties of rat-liver lysosomes. Nature (Lond.), 203: 757-778, 1964.
16. Schwartz, S. L., and Johnson, C. B. Pinocytosis as the cause of sucrose nephrosis. Nephron, 8: 246-254, 1971.
17. Straus, W. Occurrence of phagosomes and phago-lysosomes in different segments of the nephron in relation to the reabsorption, transport, digestion, and extrusion of intravenously injected horseradish peroxidase. J. Cell Biol., 21: 295-308, 1964.
18. Straus, W. Cytochemical observations on the relationship between lysosomes and phagosomes in the kidney and liver by combined staining for acid phosphatase and intravenously injected horseradish peroxidase. J. Cell Biol., 20: 497-507, 1964.
19. Straus, W. Cytochemical investigation of phagosomes and related structures in cryostat section of the kidney and liver of rats after intravenous administration of horseradish peroxidase. Exp. Cell Res., 27: 80-94, 1962.
20. Munniksma, J., Noteborn, M., Kooistra, T., Stemstra, S., Bouma, J. M. W., Gruber, M., Brouwer, A., Praaning-Van Dalen, D., and Knook, D. L. Fluid endocytosis by rat liver and spleen. Biochem. J., 192: 613-621, 1980.
21. Maack, T., Park, C. H., and Camargo, M. J. F. Renal filtration, transport and metabolism of proteins. In: D. W. Seldin and G. Giebisch (eds.). The Kidney: Physiology and Pathophysiology, Ed. 2, pp. 3005-3038. New York: Raven Press, 1992.
22. Christensen, E. I., and Maunsbach, A. B. Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule. Kidney Int., 16: 301-311, 1979.
23. Silverstein, S., Steinman, R. M., and Conn, Z. A. Endocytosis. Annu. Rev. Biochem., 46: 669-722, 1977.
24. Yamaguchi, Y., Dalle-Molle, E., and Hardison, W. G. Hepatocyte horseradish peroxidase uptake is saturable and inhibited by mannose-terminal glycoproteins. Am. J. Physiol., 264: G880-G885, 1993.
25. Ose, L., Ose, T., Reinertsen, R., and Berg, T. Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells. Exp. Cell Res., 126: 109-119, 1980.
26. 3H uptake and inhibition by cytochalsin B. J. Cell Biol., 50: 804-817, 1971.
27. Scharschmidt, B. F., Lake, J. R., Renner, E. L., Licko, V., and Van Dyke, R. W. Fluid phase endocytosis by cultured rat hepatocyles and perfused rat liver: implications for plasma membrane turnover and vesicular trafficking of fluid phase markers. Proc. Natl. Acad. Sci. USA, 83: 9488-9492, 1986.
28. Otsuka, F. L., Welch, M. J., Kilboum, M. R., Dence, C. S., Dilley, W. G., and Wells, S. A., Jr. Antibody fragments labeled with fluorine-18 and gallium-68: in vivo comparison with indium-111 and iodine-125-labeled fragments. Nucl. Med. Biol., 18: 813-816, 1991.
29. 111In-labeled monoclonal antibodies. Nucl. Med. Biol., 13: 325-334, 1986.
30. Khaw, B. A., Cooney, J., Edgington, T., and Strauss, H. W. Differences in experimental tumor localization of dual-labeled monoclonal antibody. J. Nucl. Med., 27: 1293-1299, 1986.
31. Schott, M. E., Milenic, D. E., Yokota, T., Whitlow, M., Wood, J. F., Fordyce, W. A., Cheng, R. C., and Schlom, J. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain-Fv molecules. Cancer Res., 52: 6413-6417, 1992.
32. Andrew, S. M., Ferions, A. C., Pimm, M. V., and Baldwin, R. W. A comparison of iodine and indium labeled anti CEA intact antibody. F(ab)'2 and Fab fragments by imaging tumour xenografts. Eur. J. Nucl. Med., 13: 598-604, 1988.
33. Carrasquillo, J. A., Mulshine, J. L., Bunn, P. A., Jr, Reynolds, J. C., Foon, K. A., Schroff, R. W., Perentesis, P., Steis, R. G., Keenan, A. M., Horowitz, M., and Larson, S. M. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma. J. Nucl. Med., 28: 281-287, 1987.
34. Yokoyama, K., Carrasquillo, J. A., Chang, A. E., Colcher, D., Roselli, M., Sugarbaker, P., Sindelar, W., Reynolds, J. C., Perentesis, P., and Gansow, O. A. Differences in biodistribution of indium-111 -and iodine-131 -labeled B72.3 monoclonal antibodies in patients with colorectal cancer. J. Nucl. Med., 30: 320-327, 1989.
35. Pimm, M. V., Perkins, A. C., and Baldwin, R. W. Differences in tumour and normal tissue concentrations of iodine- and indium-labeled monoclonal antibody. II. Biodistribution studies in mice with human tumour xenografts. Eur. J. Nucl. Med., 11: 300-304, 1985.
36. Larson, S. M., and Carrasquillo, J. A. Advantages of radioiodine over radioindium labeled monoclonal antibodies for imaging solid tumors. Nucl. Med. Biol., 75: 231-233, 1988.
37. 111In. Cancer Res., 47: 1149-1154, 1987.
38. Esteban, J. M., Schlom, J., Gansow, O. A., Atcher, R. W., Brechbiel, M. W., Simpson, D. E., and Colcher, D. C. New method for chelation of indium-111 to monoclonal antibodies: biodistribution and imaging athymic mice bearing human colon carcinoma xenografts. J. Nucl. Med., 28: 861-870, 1987.
39. Fischman, A. J., Khaw, B. A., and Strauss, H. W. Quo vadis radioimmune imaging. J. Nucl. Med., 30: 1911-1915, 1989.
40. Rogers, B. E., Franano, F. N., Duncan, J. R., Edwards, W. B., Anderson, C. J., Connett, J. M., and Welch, M. J. Identification of metabolites of In-111-DTPAmonoclonal antibodies and antibody fragments in vivo. Cancer Res., 55 (Suppl.): 5714s-5720s, 1995.
41. Anderson, C. J., Pajeau, T. S., Edwards, W. B., Sherman, E. L. C., Rogers, B. E., and Welch, M. J. In vitro and in vivo evaluation of copper-64-Octreotide conjugates. J. Nucl. Med., 36: 2315-2325, 1995.
42. Reubi, J. C., Kvols, L., Krenning, E., and Lamberts, S. W. J. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism, 39: 78-91, 1990.
43. Reubi, J. C., Horisoerger, U., Essed, C. E., Jeekel, J., Klijn, J. G. H., and Lamberts, S. W. J. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology, 95: 760-763, 1988.
44. Srikant, C. B., and Patel, Y. C. Somatostatin receptors on rat pancreatic acinar cells. Pharmacological and structural characterization and demonstration of down-regulation in streptozotocin diabetes. J. Biol. Chem., 261: 7690-7696, 1986.
45. Breeman, W. A., Kwekkeboom, D. J., Kooij, P. P., Bakker, W. H., Hofland, L. J., Visser, T. J., Ensing, G. J., Lamberts, S. W., and Krenning, E. P. Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J. Nucl. Med., 36: 623-627, 1995.
46. Bakker, W. H., Krenning, E. P., Reubi, J. C., Breeman, W. A., Setyono-Han, B., de Jong, M., Kooij, P. P., Bruns, C., van Hagen, P. M., Marbach, P., Visser, T. J., Pless, J., and Lamberts, S. W. J. In vivo application of [111 In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci., 49: 1593-1601, 1991.
47. Straus, W. Concentration of acid phosphatase, ribonuclease, desoxyribonuclease, β-glucuronidase, and cathepsin in "droplets" isolated from the kidney cells of normal rats. J. Biophys. Biochem. Cytol., 2: 513-521, 1956.
48. Weibel, E. R., Staubli, W., Gnagi, H. R., and Hess, F. A. Correlated morphometric and biochemical studies of the liver cell. 1. Morphometric model, stereologic methods and normal morphometric data for rat liver. J. Cell Biol., 42: 68-91, 1969.
49. Blouin, A., Bolender, R. P., and Weibel, E. R. Distribution of organelles and membrances between hepatocytes and nonhepatocytes in the rat liver parenchyma. J. Cell Biol., 72: 441-455, 1977.
50. Wattiaux, R., Gentinne, F., Jadot, M., Dubois, F., and Wattiaux-De, C. S. Chloroquine allows to distinguish between hepatocyte lysosomes and sinusoidal cell lysosomes. Biochem. Biophys. Res. Commun., 190: 808-813, 1993.
51. Ryser, H. J-P. A membrane effect of basic polymers dependent on molecular size. Nature (Lond.), 215: 934-936, 1967.
52. Ryser, H. J-P. Uptake of protein by mammalian cells: an underdeveloped area. Science (Washington DC), 159: 390-396, 1968.
53. Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S-M., Lee, T., Pope, S. H., Riordan, G. S., and Whitlow, M. Single-chain antigenbinding proteins. Science (Washington DC), 242: 423-426, 1988.
54. Behr, T. M., Sharkey, R. M., Juweid, M., Aninpot, R., Griffiths, G. L., and Goldenberg, D. M. Reduction of kidney uptake of radiolabeled monoclonal antibody (MAb) fragments: preclinical and initial clinical results. J. Nucl. Med., 36: 19P, 1995.
55. Behr, T. M., Becker, W. S., Sharkey, R. M., Juweid, M. E., Dunn, R. M., Bair, H-J., Wolf, F. G., and Goldenberg, D. M. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J. Nucl. Med., 37: 829-833, 1996.
56. 177Lu]α-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Rab radioimmunoconjugate. Cancer Res., 55: 5288-5295, 1995.
57. Pimm, M. V., and Gribben, S. J. Prevention of renal tubule re-absorption of radiometal (indium-Ill) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. Eur. J. Nucl. Med., 21: 663-665, 1994.
58. Yokota, T., Milenic, D. E., Whitlow, M., Wood, J. F., Hubert, S. L., and Schlom, J. Microautoradiographic analysis of the normal organ distribution of radioiodmated single-chain Fv and other immunoglobulin forms. Cancer Res., 53: 3776-3783, 1993.
59. Bulger, R. E. The urinary system. In: L. Weiss and R. O. Greep (eds.), Histology, Ed. 4, pp. 832-871. New York: McGraw-Hill, Inc., 1977.
60. 125I-labeled homologous albumin by rat kidney proximal tubule cells. A study of microperfused single proximal tubules by electron microscopic autoradiography and histochemistry. J. Ultrastruc. Res., 15: 197-241, 1966.
61. Dorr, U., Rath, U., Sautter-Bihl M-L., Guzman, G., Bach, D., Adrian, H-J., and Bihl, H. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur. J. Nucl. Med., 20: 431-433, 1993.
62. Soresi, E., Bombardieri, E., Chiti, A., Boffi, R., Invemizzi, G., Crippa, F., and Maffioli, L. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer. Tumori, 81: 125-127, 1995.
63. Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russel, D. W., and Schneider, W. J. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu. Rev. Cell Biol., 1: 1-39, 1985.
64. Schwartz, A. L., Fridovich, S. E., and Lodish, H. F. Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. J. Biol. Chem., 257: 4230-4237, 1982.
65. Bass, L. A., Lanahan, M. V., Duncan, J. R., Stephenson, M. T., Cristel, M. E., and Anderson, C. J. In vivo metabolism of In-111-octreotide. J. Nucl. Med., 37: 201P, 1996.
66. Krieger, M., and Herz, J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem., 63: 601-637, 1994.
67. Khaw, B. A., Strauss, H. W., and Narula, J. "Magic bullets:" from muskets to smart bombs!!! J. Nucl. Med., 34: 2264-2268, 1993.
68. Lehninger, A. L., Nelson, D. L., and Cox, M. M. Principles of Biochemistry, 2nd Ed., p. 229. New York: Worth Publishers, 1993.
69. Fersht, A. Enzyme Structure and Mechanism, 2nd Ed., p. 283. New York: W. H. Freeman & Co., 1985.
70. Krenning, E. P., Kooij, P. P., Bakker, W. H., Breeman, W. A., Postema, P. T., Kwekkeboom, D. J., Oei, H. Y., de Jong, M., Visser, T. J., Reijs, A. E., and Lamberts, S. W. J. Radiotherapy with a radiolabeled somatostatin analogue. [111 In-DTPA-DPhel]-octreotide. A case history. Ann. NY Acad. Sci., 733: 496-506, 1994.
71. van Osdol, W., Fujimori, K., and Weinstein, J. N. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier." Cancer Res., 51: 4776-4784, 1991.
72. Juweid, M., Neumann, R., Paik, C., Perez-Bacete, M. J., Sato, J., van Osdol, W., and Weinstein, J. N. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res., 52: 5144-5153, 1992.
73. Baxter, L. T., Zhu, H., Mackensen, D. G., and Jain, R. K. Physiological based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res., 54: 1517-1528, 1994.
74. 1 F(ab′)2, and Fab′ in mice. Cancer Res., 46: 3969-3978, 1986.
75. 111In-labeled monoclonal antibody in humans. Cancer Res., 47: 3328-3336, 1987.
76. Jain, R. K. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res., 50 (Suppl.): 814s-819s, 1990.
77. Gafford, J. T., Skidgel, R. A., Erdos, E. G., and Hersh, L. B. Human kidney "enkepahlinase," a neutral metalloendopeptidase that cleaves active peptides. Biochemistry, 22: 3265-3271, 1983.
78. 111In-labeled anti-carcinoembryonic antigen monoclonal antibody by specific antibody pretreatment in tumor bearing mice. Cancer Res., 50 (Suppl.): 846s-851s, 1990.
79. Andersson, H. C., Kohn, L. D., Bernardini, I., Blom, H. J., Tietze, F., and Gahl, W. A. Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system h. J. Biol. Chem., 265: 10950-10954, 1990.
80. Press, O. W., Shan, D., Howell-Clark, J., Eary, J., Appelbaum, F. R., Matthews, D., King, D. J., Haines, A. M. R., Hamann, P., Hinman, L., Shochat, D., and Bernstein, I. D. Comparative metabolism and retention of iodine-125, yttrium-90, and indium111 radioimmunoconjugates by cancer cells. Cancer Res., 56: 2123-2129, 1996.
81. 125I radiolabeled T101 anti-CD5 monoclonal antibody. Nucl. Med. Biol., 17: 201-207, 1990.
82. Geissler, F., Anderson, S. K., Venkatesan, P., and Press, O. Intracellular catabolism of radiolabeled anti-μ antibodies by malignant B-cells. Cancer Res., 52: 2907-2915, 1992.
83. Kyriakos, R. J., Shih, L. B., Ong, G. L., Patel, K., Goldenberg, D. M., and Mattes, M. J. The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res., 52: 835-842, 1992.
84. Shih, L. B., Thorpe, S. R., Griffiths, G. L., Diril, H., Ong, G. L., Hansen, H. J., Goldenberg, D. M., and Martes, M. J. The processing and fate of antibodies and their radioiahe Is bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. J. Nucl. Med., 35: 899-908, 1994.
85. Li, M., and Meares, C. F. Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. Bioconjug. Chem., 4: 275-283, 1993.
86. Deshpande, S. V., DeNardo, S. J., Meares, C. F., McCall, M. J., Adams, G. P., and DeNardo, G. L. Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver Nucl. Med. Bio., 16: 587-597, 1989.
87. Paik, C. H., Yokoyama, K., Reynolds, J. C., Quadri, S. M., Min, C. Y., Shin, S. Y., Maloney, P. J., Larson, S. M., and Reba, R. C. Reduction of background activities by introduction of a diester linkage between antibody and a chelate in radioimmunodetection of tumor. J. Nucl. Med., 10: 1693-1701, 1989.
88. Arano, Y., Matsushima, H., Tagawa, M., Koizumi, M., Endo, K., Konishi, J., and Yokoyama, A. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides. Bioconjug. Chem., 2: 71-76, 1991.
89. 111In-cyclohexyl EDTA derivatives and F(ab′)2 fragments of anti-carcinoembryonic antigen antibody. II. Comparative pharniacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice. Nucl. Med. Biol., 20: 763-771, 1993.
90. Elferink, R. P. J. O., Meijer, D. K. F., Kuipers, F., Jansen, P. L. M., Groen, A. K., and Groothuis, G. M. M. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim. Biophys. Acta, 1241: 215-268, 1995.
91. Pritchard, J. B., and Miller, D. S. Mechanisms mediating renal secretion of organic anions and cations. Physiol. Rev., 73: 765-796, 1993.
92. Kinuya, S., Jeong, J. M., Garmestani, K., Saga, T., Camera, L., Brechbiel, M. W., Gansow, O. A., Carrasquillo, J. A., Neumann, R. D., and Paik, C. H. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood, J. Nucl. Med., 35: 1851-1857, 1994.